https://www.oncologynurseadvisor.com Fri, 01 Mar 2024 14:51:43 +0000 en-US hourly 1 https://wordpress.org/?v=6.4.3 https://www.oncologynurseadvisor.com/wp-content/uploads/sites/13/2024/01/cropped-CTA-ONA-HEM-favicon-32x32.png https://www.oncologynurseadvisor.com 32 32 https://www.oncologynurseadvisor.com/home/cancer-types/hematologic-cancers/financial-toxicity-hematologic-cancer-risk-caregiver-bmt-patients/ Fri, 01 Mar 2024 14:20:00 +0000 https://www.oncologynurseadvisor.com/?p=117001 https://www.oncologynurseadvisor.com/home/headlines/conference-coverage/ash-2023/coping-strategies-used-pre-hct-affect-qol-psychological-distress/ Sun, 10 Dec 2023 17:40:00 +0000 https://www.oncologynurseadvisor.com/?p=114788 A secondary analysis of supportive care trial data demonstrated that an approach-oriented coping strategy improved QOL and psychological distress in patients with hematologic cancer undergoing HCT.]]> https://www.oncologynurseadvisor.com/home/cancer-types/multiple-myeloma/response-after-auto-hsct-predicts-pfs-os-in-younger-patients-with-mm/ Thu, 06 Jul 2023 14:30:00 +0000 https://www.oncologynurseadvisor.com/?p=109055 Survival outcomes have improved for younger patients with multiple myeloma, especially among those who underwent auto-HSCT after 2010.]]> https://www.oncologynurseadvisor.com/reports/telephone-based-wli-successful-in-breast-cancer-survivors/ Fri, 02 Jun 2023 14:00:00 +0000 https://www.oncologynurseadvisor.com/?p=108130 Results of the Breast Cancer Weight Loss trial were presented at the 2023 ASCO Annual Meeting. ]]> https://www.oncologynurseadvisor.com/reports/breast-cancer-better-counseling-uptake-brca12-hereditary-treatment-risk/ Sat, 29 Apr 2023 13:00:00 +0000 https://www.oncologynurseadvisor.com/?p=107080 A review of the literature identified interventions that may increase understanding and uptake of genetic testing for BRCA1/2 variants.]]> https://www.oncologynurseadvisor.com/reports/hsct-advanced-practice-nurse-pharmacist-collaboration-leads-improved-outcomes/ Fri, 28 Apr 2023 13:00:00 +0000 https://www.oncologynurseadvisor.com/?p=107076 A project designed to improve the interaction within a multidisciplinary team on a HSCT unit was presented at the 48th Annual ONS Congress.]]> https://www.oncologynurseadvisor.com/reports/sarcoma-first-assessment-tool-identifies-early-onset-neurotixicity-regimen-2/ Fri, 28 Apr 2023 13:00:00 +0000 https://www.oncologynurseadvisor.com/?p=107078 A nurse-led team developed a tool to assess patients with sarcoma undergoing multiday ifosfamide regimens for early signs of neurotoxicity.]]> https://www.oncologynurseadvisor.com/reports/gynecologic-cancer-characteristics-treatment-options-patients-risk/ Sun, 19 Mar 2023 16:30:00 +0000 https://www.oncologynurseadvisor.com/?p=105997 A presentation at the 2023 ONA Summit reviewed diagnosis and treatment recommendations for uterine, ovarian, and endometrial cancers.]]> https://www.oncologynurseadvisor.com/reports/acute-myeloid-leukemia-achieving-managing-patient-care-treatment-risk/ Fri, 17 Mar 2023 16:15:00 +0000 https://www.oncologynurseadvisor.com/?p=105945 The unique needs of patients with AML undergoing maintenance therapy, including care disparities and challenges, are discussed at the 2023 ONA Summit.]]> https://www.oncologynurseadvisor.com/home/cancer-types/breast-cancer/breast-cancer-endocrine-therapy-adverse-effects-persist-treatment-risk/ Fri, 13 Jan 2023 16:00:00 +0000 https://www.oncologynurseadvisor.com/?p=104334 A follow-up study assessed long-term effects of endocrine therapy in breast cancer survivors who reported endocrine therapy-related effects in a previous study.]]>